In May, the NSF’s National Center for Science and Engineering Statistics published an InfoBrief with its figures on federal funding for R&D for fiscal 2012–14 (FY12–14). The data were collected from February to August of 2014 from the “NSF Survey of Federal Funds for Research and Development: FYs 2013–15,” which was sent to federal agencies. […]
The European Commission decided last month to reduce the €2.7 billion ($2.9 billion) in budget cuts to Horizon 2020 that were previously planned to €500 million. The budgets of the European Research Council, the Marie Sklodowska-Curie Actions and the “widening participation” program will be preserved. The EU Budget Commissioner, Kristalina Georgieva, indicated that budget cuts […]
A recent survey of 40 senior executives in China, across the aerospace and defense, automotive, consumer products, engineering and industrial products, and metal industries, and conglomerates, found that most plan to increase R&D spending. While only 65% of the companies spent 4% or more of revenues on R&D in the past two years, 93% plan […]
By 2025, according to Citigroup estimates, the South Korean market for biosimilars will reach $18 billion, with companies investing $110 billion in their development. South Korea aims to build this market to order to elevate its status as a global pharmaceutical supplier, increase its pharmaceutical exports to $20.5 billion and have 3 of the top […]
US bulk chemical producers are benefiting from the rise in US shale gas output and subsequent lower gas prices. In contrast to producers in other regions that rely on oil products, such as naptha, for feedstock, US companies’ access to shale gas provides them with cheaper feedstock, including ethane. Commodities chemicals provider LyondellBasell is an […]
The fiscal 2016 budget for Japan was passed in April, totaling ¥96.34 trillion ($775 billion). At ¥3,447 billion, funding for science, technology and innovation declined 5.0%. The Ministry of Education, Culture, Sports, Science and Technology received ¥2,280 billion, down 1.4%. Much of the change reflects decreased subsidies for the country’s national universities. The Ministry of […]
Using biomarkers from patients’ tumors in clinical trials may not be as reliable as genetic variation in determining who will benefit most from particular drug treatments. For example, the protein levels detected in a test may differ based the part of a tumor from which a biopsy was obtained and the extent of a cancer’s […]
Expanding Markets Lift Affymetrix Q1 Sales Affymetrix first quarter sales grew 6.9%, 9% excluding currency, to $88.7 million. The negative impact from currency was partially reduced by hedging gains of $2.2 million. Product sales grew 7.7% to $79.4 million. Consumables sales grew 9.4%, and Instruments sales fell 23.5% to account for 86% and 3% of […]
A paper published this month estimated that each year in the US about $28.2 billion, or half of the total spending on preclinical research, is used for preclinical studies that are not reproducible. “[T]he existence and propagation of one or more errors, flaws, inadequacies or omissions . . . that prevent replication of results” were […]
The American Society of Mass Spectrometry (ASMS) held its 63rd annual conference from May 31 to June 4 at the downtown convention center in St. Louis, Missouri. Attendance totaled 6,101, falling 8.9% from last year (see IBO 6/30/14). MS companies at the conference focused on total-package solutions for research needs, unlike in previous years, when […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
